EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kezar Life Sciences's enterprise value is $-121.45 Mil.
Kezar Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7.00 Mil. Therefore, Kezar Life Sciences's EV-to-Revenue for today is -17.35.
The historical rank and industry rank for Kezar Life Sciences's EV-to-Revenue or its related term are showing as below:
KZR'
s EV-to-Revenue Range Over the Past 10 Years
Min: -20.93 Med: -17.74 Max: -15.36
Current: -17.41
During the past 8 years, the highest EV-to-Revenue of Kezar Life Sciences was -15.36. The lowest was -20.93. And the median was -17.74.
KZR's EV-to-Revenue is ranked better than 97.78% of 1034
companies
in the Biotechnology industry
Industry Median: 7.775
vs KZR: -17.41
The historical data trend for Kezar Life Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kezar Life Sciences's EV-to-Revenue
For the Biotechnology subindustry, Kezar Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kezar Life Sciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kezar Life Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Kezar Life Sciences's EV-to-Revenue falls into.
Kezar Life Sciences's current Enterprise Value is $-121.45 Mil.
Kezar Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kezar Life Sciences (NAS:KZR) EV-to-Revenue Explanation
Kezar Life Sciences's share price for today is $0.83.
Kezar Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kezar Life Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Kezar Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kezar Life Sciences (Kezar Life Sciences) Business Description
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KZR has been successfully added to your 